Axogen, Inc. (AXGN): Capital Expenditures
$3.75M
Year ended 2025-12-31
$6.45M
Trailing 12 months to 2026-06-30
-42.9%
3-year compound annual growth
-29.8%
5-year compound annual growth
+24.8%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.75M | +20.8% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $3.10M | -77.6% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $13.87M | -30.9% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $20.08M | -27.8% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $27.81M | +27.0% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $21.91M | +369.7% | 2023-03-14, From 2020-01-01 |
| 2019-12-31 | $4.66M | -25.8% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $6.28M | +468.5% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $1.10M | +18.7% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $931.0K | +127.7% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $408.8K | -24.6% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $542.0K | +203.2% | 2016-02-29, From 2014-01-01 |
| 2013-12-31 | $178.8K | +268.9% | 2015-03-05, From 2013-01-01 |
| 2012-12-31 | $48.5K | +135.1% | 2014-03-06, From 2012-01-01 |
| 2011-12-31 | $20.6K | n/a | 2013-08-07, From 2011-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Axogen, Inc. (AXGN) | 2025-12-31 | $3.75M | +20.8% |
| InMode Ltd. (INMD) | 2025-12-31 | $972.0K | +45.3% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $798.0K | -12.5% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $9.48M | +193.7% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $767.0K | -42.8% |
| TransMedics Group, Inc. (TMDX) | 2025-12-31 | $59.25M | -54.3% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $1.25M | +377.9% |
| Iridex Corp (IRIX) | 2026-01-03 | $143.0K | +1000.0% |
| Conmed Corp (CNMD) | 2025-12-31 | $19.81M | +51.4% |
Compare AXGN, INMD, OM, BLFS side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗